System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Izza Shahid is an expert in Cardiology at Houston Methodist (United States). Izza Shahid has authored 127 publications, the most recent in 2025. SLR score: 489 (community average: 125). How the SLR is computed.

LeadR Profile

Izza Shahid Houston Methodist United States
489 ScienceLeadR Reputation 489

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Public Health - Endocrinology - Biostatistics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Dr. Izza Shahid is a postdoctoral research fellow in the Department of Cardiology at Houston Methodist Hospital in USA. Her research focuses on cardiometabolic disease, heart failure, and preventive cardiology, with a particular emphasis on optimizing the use and intensification of guideline-directed medical therapy in heart failure. She has a special interest in evaluating the real-world effectiveness and implementation of therapeutic strategies in patients with cardiometabolic conditions.

Organizations

Career arc: 2021 - 2025
Source: PubMed

Houston Methodist

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 127

Citations

Citations: 14 618 1st author: 32 Last author: 6 Unique author: 0

Main journals

J Am Coll Cardiol 35
Circulation 12
Am J Cardiol 8
Curr Probl Cardiol 4
Lancet 4

Best Journals

Circulation 12
Lancet 4
Eur Heart J 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Climate Vulnerability Index and Incident Type 2 Diabetes in a Large Integrated Health Care System.
PMID 41348357 — diabetes mellitus, hemoglobins, incidence, climate, cohort studies, clinical medicine, risk factors, diabetes mellitus, type 2		JAMA Netw Open20251
Unfavorable Social Determinants of Health and Obesity: A Double Jeopardy for Premature Mortality.
PMID 41067122 — mortality, cardiovascular diseases, obesity, risk factors, mortality, premature		JACC Adv20250
Effect of glucagon-like peptide 1 receptor agonists on systolic blood pressure in patients with obesity, with or without diabetes: A systematic review and network meta-analysis.
PMID 40265328 — diabetes mellitus, glucagon-like peptide 1, glucagon-like peptide-1 receptor, blood, pharmaceutical preparations, blood pressure, liraglutide, network meta-analysis, obesity, weight loss, glucagon, glucagon-like peptides		Clin Obes20251
Lifestyle Interventions in Cardiovascular-Kidney-Metabolic Syndrome JACC: Advances Expert Panel.
PMID 40579052 — exercise, life style, cardiovascular diseases, kidney, diet, metabolic syndrome		JACC Adv202511
Effect of angiotensin receptor neprilysin inhibitors in patients with STEMI: a systematic review and meta-analysis.
PMID 40418165 — receptors, angiotensin, safety, myocardial infarction, heart failure, cardiovascular diseases, neprilysin, angiotensins, st elevation myocardial infarction, hypotension, therapeutics		Future Cardiol20250

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS